Global Chronic Idiopathic Constipation (CIC) Drugs Market Data Survey Report 2025
- HEY2872484
- 66 Pages
- January 2018
- Medical Devices
The global Chronic Idiopathic Constipation (CIC) Drugs market will reach Volume Million USD in 2018 with CAGR xx% 2018-2025. The main contents of the report including:
Global market size and forecast
Regional market size, production data and export & import
Key manufacturers (manufacturing sites, capacity and production, product specifications etc.)
Major Application
Major Type
Key manufacturers are included based on manufacturing sites, capacity and production, product specifications etc.:
Actavis
Chugai Pharmaceutical
Ferring International Center
Synergy Pharmaceuticals
Pfizer
GlaxoSmithKline
GlaxoSmithKline
Sanofi
Bayer
Salix Pharmaceuticals
Sucampo Pharmaceuticals
Ironwood Pharmaceuticals
Progenics Pharmaceuticals
Major applications as follows:
Hospitals & Clinics
Ambulatory Surgical Centres
Long Term Care Centres
Others
Major Type as follows:
Lubiprostone
Linaclotide
Others
Regional market size, production data and export & import:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
1 Global Market Overview
1.1 Scope of Statistics
1.1.1 Scope of Products
1.1.2 Scope of Manufacturers
1.1.3 Scope of Application
1.1.5 Scope of Regions/Countries
1.2 Global Market Size
2 Regional Market
2.1 Regional Production
2.2 Regional Demand
2.3 Regional Trade
3 Key Manufacturers
3.1 Actavis
3.1.2 Company Information
3.1.2 Product Specifications
3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.2 Chugai Pharmaceutical
3.2.1 Company Information
3.2.2 Product Specifications
3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.3 Ferring International Center
3.3.1 Company Information
3.3.2 Product Specifications
3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.4 Synergy Pharmaceuticals
3.4.1 Company Information
3.4.2 Product Specifications
3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.5 Pfizer
3.5.1 Company Information
3.5.2 Product Specifications
3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.6 GlaxoSmithKline
3.6.1 Company Information
3.6.2 Product Specifications
3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.7 GlaxoSmithKline
3.7.1 Company Information
3.7.2 Product Specifications
3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.8 Sanofi
3.8.1 Company Information
3.8.2 Product Specifications
3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.9 Bayer
3.9.1 Company Information
3.9.2 Product Specifications
3.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.10 Salix Pharmaceuticals
3.10.1 Company Information
3.10.2 Product Specifications
3.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.11 Sucampo Pharmaceuticals
3.12 Ironwood Pharmaceuticals
3.13 Progenics Pharmaceuticals
4 Major Application
4.1 Hospitals & Clinics
4.1.1 Overview
4.1.2 Hospitals & Clinics Market Size and Forecast
4.2 Ambulatory Surgical Centres
4.2.1 Overview
4.2.2 Ambulatory Surgical Centres Market Size and Forecast
4.3 Long Term Care Centres
4.3.1 Overview
4.3.2 Long Term Care Centres Market Size and Forecast
4.4 Others
4.4.1 Overview
4.4.2 Others Market Size and Forecast
5 Market by Type
5.1 Lubiprostone
5.1.1 Overview
5.1.2 Lubiprostone Market Size and Forecast
5.2 Linaclotide
5.2.1 Overview
5.2.2 Linaclotide Market Size and Forecast
5.3 Others
5.3.1 Overview
5.3.2 Others Market Size and Forecast
6 Conclusion
Tab Regional Production 2011-2017 (Volume)
Tab Regional Demand and CAGR 2011-2017 (Million USD)
Tab Regional Demand and CAGR 2011-2017 (Volume)
Tab Regional Demand Forecast and CAGR 2018-2025 (Million USD)
Tab Regional Demand Forecast and CAGR 2018-2025 (Volume)
Tab Regional Export 2011-2017 (Million USD)
Tab Regional Export 2011-2017 (Volume)
Tab Regional Import 2011-2017 (Million USD)
Tab Regional Import 2011-2017 (Volume)
Tab Sales Revenue, Volume, Price, Cost and Margin of Actavis
Tab Sales Revenue, Volume, Price, Cost and Margin of Chugai Pharmaceutical
Tab Sales Revenue, Volume, Price, Cost and Margin of Ferring International Center
Tab Sales Revenue, Volume, Price, Cost and Margin of Synergy Pharmaceuticals
Tab Sales Revenue, Volume, Price, Cost and Margin of Pfizer
Tab Sales Revenue, Volume, Price, Cost and Margin of GlaxoSmithKline
Tab Sales Revenue, Volume, Price, Cost and Margin of GlaxoSmithKline
Tab Sales Revenue, Volume, Price, Cost and Margin of Sanofi
Tab Sales Revenue, Volume, Price, Cost and Margin of Bayer
Tab Sales Revenue, Volume, Price, Cost and Margin of Salix Pharmaceuticals
Tab Sales Revenue, Volume, Price, Cost and Margin of Sucampo Pharmaceuticals
Tab Sales Revenue, Volume, Price, Cost and Margin of Ironwood Pharmaceuticals
Tab Sales Revenue, Volume, Price, Cost and Margin of Progenics Pharmaceuticals
Similar Reports
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
